Tisdag 26 November | 05:47:58 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-03-28 09:00 Bokslutskommuniké 2024
2024-11-15 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-07-01 - X-dag ordinarie utdelning MAGNA 0.00 SEK
2024-06-28 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q1
2024-04-26 - Extra Bolagsstämma 2024
2024-03-29 - Bokslutskommuniké 2023
2023-11-24 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-06-22 - Årsstämma
2023-06-01 - Kvartalsrapport 2023-Q1
2023-05-16 - X-dag ordinarie utdelning MAGNA 0.00 SEK
2023-03-31 - Bokslutskommuniké 2022
2023-01-20 - Extra Bolagsstämma 2022
2022-11-23 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-21 - X-dag ordinarie utdelning MAGNA 0.00 SEK
2022-06-20 - Årsstämma
2022-05-25 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-24 - Kvartalsrapport 2021-Q2
2021-06-29 - X-dag ordinarie utdelning MAGNA 0.00 SEK
2021-06-28 - Årsstämma
2021-05-25 - Kvartalsrapport 2021-Q1
2021-03-09 - Extra Bolagsstämma 2021
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-08-27 - Kvartalsrapport 2020-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
Magnasense är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling av olika läkemedelskandidater. Produktportföljen är bred och inkluderar huvudsakligen läkemedel för behandling av multipel skleros. Utöver huvudverksamheten erbjuds tillhörande kringtjänster. Verksamheten drivs i samarbete med övriga läkemedelsaktörer, där störst närvaro återfinns inom Norden.
2024-07-31 15:45:00

Magnasense today announced the appointment of Vicki Johnson as interim Chief Financial Officer (CFO), succeeding Christel Dahlberg, who has resigned today due to private health reasons.

Vicki Johnson brings extensive experience in finance to her new role. She holds a Master's Degree in Chemistry from Oxford University and began her career at EY LLP, where she qualified as a Chartered Accountant (CA). Vicki has held various finance roles across professional services, manufacturing, and technology sectors, with expertise in financial reporting, audit, budgeting, forecasting, tax, and treasury.

For the past five years, Vicki Johnson has been a financial consultant with CFPro Limited (now part of BKL) in the UK, providing CFO services to a FTSE AIM-listed manufacturing company and a privately owned technology company.

"We are grateful to Christel Dahlberg for her contributions to Magnasense and wish her the best," said CEO Marco Witteveen. "We are confident that Vicki Johnson's leadership will guide Magnasense through this transition and advance our financial strategy."

"I am honored to step into the role of interim CFO at Magnasense," said Vicki Johnson. "I look forward to working with the executive team to drive our strategic goals and contribute to our future success."

Vicki Johnson has been appointed interim CFO starting immediately, while the recruitment of a new CFO is ongoing. The board and executive team are committed to ensuring a smooth transition and continued excellence in financial management.